Literature DB >> 12660019

Receptor-binding studies of 1-N-substituted melatonin analogues.

Alfonso Lira-Rocha1, Ofelia Espejo-González, Elia B Naranjo-Rodríguez.   

Abstract

In order to analyse the relevance of the indole electronic region in the binding of melatonin to its receptors, we prepared several analogues with p-H, p-NO(2), p-MeO, p-F and p-Me of benzyl, benzoyl and phenyl substituents at position 1 of the melatonin skeleton. The electronic properties of the analogues, as calculated with the semiempirical method AM1, were correlated with their affinity for the melatonin receptor from chicken brain membranes. Different trends were observed for each compound series. Compound 5c, with a p-NO(2)-benzoyl group, showed the best affinity indicating the importance of a polar bulky group in the receptor interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12660019     DOI: 10.1016/s0223-5234(02)01410-1

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Molecular modeling study of the mechanism of ligand binding to human melatonin receptors.

Authors:  A E Voronkov; A A Ivanov; I I Baskin; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2005 Jul-Aug       Impact factor: 0.788

Review 2.  Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders.

Authors:  Annia Galano; Eduardo G Guzmán-López; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

3.  Design and Validation of the First Family of Photo-Activatable Ligands for Melatonin Receptors.

Authors:  Gloria Somalo-Barranco; Carme Serra; David Lyons; Hugh D Piggins; Ralf Jockers; Amadeu Llebaria
Journal:  J Med Chem       Date:  2022-08-05       Impact factor: 8.039

Review 4.  Homology models of melatonin receptors: challenges and recent advances.

Authors:  Daniele Pala; Alessio Lodola; Annalida Bedini; Gilberto Spadoni; Silvia Rivara
Journal:  Int J Mol Sci       Date:  2013-04-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.